Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF LEGAL OFFICER, SECRETARY | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 117,616 |
Ending reported balance
After 2026-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 5,350 · Balance 115,611 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 9,152 · Balance 124,763 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-01 · Exercise / conversion · Acquired 426 · Balance 125,189 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2026-09-02 · Sale · Disposed 7,573 · Balance 117,616 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,700 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Exercise / conversion · Disposed 5,350 · Balance 10,700 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 54,918 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Exercise / conversion · Disposed 9,152 · Balance 54,918 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,553 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Exercise / conversion · Disposed 426 · Balance 2,553 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 913 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,741 Underlying: Common Stock · 913 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,524 | $80.04 | $282,060.96 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,164 | $38.55 | $44,872.20 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 913 | $12.21 | $11,147.73 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,165 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,608 Underlying: Common Stock · 1,165 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,446 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,594 Underlying: Common Stock · 1,446 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 914 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,654 Underlying: Common Stock · 914 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,525 | $79.12 | $278,898.00 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,165 | $38.55 | $44,910.75 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,446 | $22.30 | $32,245.80 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 914 | $12.21 | $11,159.94 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 22,127 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 11 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,773 Underlying: Common Stock · 22,127 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,128 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 10 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,040 Underlying: Common Stock · 10,128 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,308 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,568 Underlying: Common Stock · 7,308 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,823 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,823 shares Expires 2025-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,734 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 50,955 | $75.00 | $3,821,625.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 22,127 | $38.55 | $852,995.85 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 10,128 | $22.30 | $225,854.40 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,308 | $12.21 | $89,230.68 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,823 | $9.60 | $17,500.80 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,734 | $8.71 | $23,813.14 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-007873 · edgar.xml · derivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,272 Underlying: Common Stock · 1,137 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On June 14, 2017, the reporting person was granted 4,545 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On June 14, 2017, the reporting person was granted 4,545 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,137 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-007873 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 23:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003464 · edgar.xml · derivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,905 Underlying: Common Stock · 1,953 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 7,811 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. F3 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 7,811 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 23:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,953 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003464 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 10,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003464 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,363 Underlying: Common Stock · 10,363 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003464 · edgar.xml · derivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,491 Underlying: Common Stock · 3,745 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 11,236 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 11,236 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003464 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,168 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 914 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,876 Underlying: Common Stock · 914 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 455 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common Stock · 455 shares Expires 2025-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,734 Underlying: Common Stock · 2,734 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,550 | $61.69 | $342,379.50 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 914 | $12.21 | $11,159.94 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 455 | $9.60 | $4,368.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,734 | $8.71 | $23,813.14 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,615 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 913 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,790 Underlying: Common Stock · 913 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 456 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,278 Underlying: Common Stock · 456 shares Expires 2025-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,468 Underlying: Common Stock · 2,734 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,500 | $53.80 | $295,900.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 913 | $12.21 | $11,147.73 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 456 | $9.60 | $4,377.60 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,734 | $8.71 | $23,813.14 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,446 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,062 Underlying: Common Stock · 1,446 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 914 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,703 Underlying: Common Stock · 914 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.